mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.01 |
0.8 |
mRNA |
fingolimod |
CTRPv2 |
pan-cancer |
AAC |
-0.01 |
0.8 |
mRNA |
BMS-536924 |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |
mRNA |
isonicotinohydroxamic acid |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.8 |
mRNA |
AT7867 |
CTRPv2 |
pan-cancer |
AAC |
0.01 |
0.8 |
mRNA |
pifithrin-alpha |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |
mRNA |
canertinib |
CTRPv2 |
pan-cancer |
AAC |
0.01 |
0.8 |
mRNA |
Rapamycin |
CTRPv2 |
pan-cancer |
AAC |
0.0097 |
0.8 |
mRNA |
ML162 |
CTRPv2 |
pan-cancer |
AAC |
0.0092 |
0.8 |
mRNA |
compound 1B |
CTRPv2 |
pan-cancer |
AAC |
-0.01 |
0.8 |